University of Groningen, University Medical Center Groningen, Department of Radiation Oncology, Groningen, The Netherlands.
Liv Hospital Ulus, Department of Radiation Oncology, Istanbul, Turkey.
Pract Radiat Oncol. 2021 Jul-Aug;11(4):272-281. doi: 10.1016/j.prro.2021.01.008. Epub 2021 Feb 5.
There are no international guidelines for optimal needle insertion during interstitial intracavitary brachytherapy (IS-ICBT) for cervical cancer. We aimed to investigate the clinical feasibility and added value of computed tomography (CT) guidance to optimize needle insertion in IS-ICBT using the Utrecht applicator and to evaluate needle shifts.
We enrolled 24 patients who were treated with interstitial-brachytherapy. Two CT scans each were performed for every patient: (1) after applicator insertion without needles (CT) and (2) after needle insertion (CT). In addition to magnetic resonance imaging after external-beam radiation therapy, CT was used to determine optimal needle locations and insertion lengths based on applicator and organs at risk positioning on the day of treatment; CT was used for IS-ICBT planning. The needle-channel axis was used as a reference to determine needle-shift evolution.
A total of 266 interstitial needles were inserted in 76 of 93 BT fractions with high intra- and interpatient variations in the number of inserted needles. Based on CT findings, needle insertion was avoided in 9, 4, 2, and 2 patients at the first, second, third, and fourth fractions, respectively. The unloaded needle frequency was 4%. Average needle contribution to total dwell time was 37.2% ± 19.2%. Shifting was observed in 68% of the needles (mean shift 2.0 ± 2.3 mm), mostly in the posterior direction, and in needles with a larger insertion length. Needle reinsertion was not needed in any patient. No complication due to needle insertion was observed, except for minor vaginal bleeding in 1 patient after needle removal.
The adaptive CT-guided IS-ICBT application was feasible and resulted in fewer unloaded needle insertions or complications and more efficient use with higher needle contribution to the treatment. Needle shift was frequent but did not require needle reinsertion with the proposed method.
宫颈癌间质腔内近距离放疗(IS-ICBT)中,目前尚无最佳针道插入的国际指南。本研究旨在探索 CT 引导下优化 Utrecht 施源器中 IS-ICBT 针道插入的临床可行性和附加价值,并评估针道移位。
我们共纳入 24 例接受间质内近距离放疗的患者。每位患者进行两次 CT 扫描:(1)无针插入时施源器插入后(CT1);(2)针插入后(CT2)。除外照射后行磁共振成像外,还使用 CT 基于施源器和危及器官定位确定治疗当天的最佳针道位置和插入长度;CT 用于 IS-ICBT 计划。以针道轴为参考,确定针道移位的演变。
76 个分次中 93 个分次共插入 266 根间质针,患者间和患者内插入针的数量存在较大差异。根据 CT 结果,分别有 9、4、2 和 2 例患者在第 1、2、3 和 4 个分次时避免了针道插入。无载针率为 4%。平均针道贡献总驻留时间为 37.2%±19.2%。68%的针道(平均移位 2.0±2.3mm)出现移位,主要为向后移位,且见于插入长度较大的针道。没有患者需要重新插入针道。除 1 例患者在拔出针后出现轻微阴道出血外,未观察到因针道插入引起的任何并发症。
适应性 CT 引导的 IS-ICBT 应用是可行的,可减少未载针的插入或并发症,更高效地利用针道,提高针道对治疗的贡献。针道移位较常见,但采用本研究提出的方法无需重新插入针道。